Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Ovarian Neoplasms 8Breast Neoplasms 8Carcinoma, Ovarian Epithelial 4Carcinoma, Non-Small-Cell Lung 4Fallopian Tube Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Esophageal Squamous Cell Carcinoma 2Carcinoma 2Uterine Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Unresectable Stage III NSCLC 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thrombocytopenia 1Primary Breast Cancer 1Pharyngeal Neoplasms 1Penile Neoplasms 1Pathologic Complete Response 1Paranasal Sinus Neoplasms 1Ovarian Diseases 1Neutropenia 1Neoplasms, Unknown Primary 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 8ferric carboxymaltose 7fludarabine 4Cyclophosphamide 4Busulfan 4Blood Transfusion 4fludarabine phosphate 3Filgrastim 3Erythrocyte Transfusion 3Cyclosporine 3Biopsy 3Antilymphocyte Serum 3thymoglobulin 2ruxolitinib 2iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2ferric gluconate 2Vitamin B 12 2Thiotepa 2Therapeutics 2Taxes 2Surveys and Questionnaires 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Lenalidomide 2Folic Acid 2Ferric Oxide, Saccharated 2Carboplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Anemia × CP protocol × Clear all
NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Cairo University

Phase 1/2 Completed
49 enrolled
Classical hematology

Anemia, Neutropenia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡